Stocks to Watch Tomorrow

Stocks to Watch Tomorrow

Maruti Suzuki's price hike, Aurobindo Pharma's regulatory approval in Brazil and JSW Infrastructure's healthy quarterly earnings could keep these stocks in focus in Wednesday's trading session.

Key Takeaways

The Indian stock market ended lower for the second consecutive session on Tuesday, July 21, as persistent geopolitical tensions in the Middle East and continued weakness in HDFC Bank weighed on investor sentiment. Elevated crude oil prices also remained a key concern, fuelling worries over inflation and corporate profitability.

Looking for Short-Term Trading Opportunities with Overnight Potential?
Explore DSIJ’s Pop BTST - a research-driven trading service focused on technically strong momentum stocks designed for Buy Today, Sell Tomorrow (BTST) opportunities.
Download Free Service Brochure

At the closing bell, the Nifty 50 slipped 50.80 points, or 0.21 per cent, to settle at 24,187.70. The Sensex declined 238.41 points, or 0.31 per cent, to close at 77,470.11.

Against this backdrop, the following stocks are likely to remain in focus during Wednesday's trading session.

Also Read - These Small Cap Mutual Funds Turned Rs 5 Lakh Into Over Rs 32 Lakh

1. Maruti Suzuki India Ltd

Maruti Suzuki India Ltd informed exchanges that it will increase prices across its vehicle portfolio by up to Rs 30,000 from August 2026. The country's largest passenger vehicle maker said the decision follows a sustained rise in input costs despite continued efforts to reduce expenses through cost optimisation measures.

According to the company, inflationary pressures and an adverse cost environment have made it necessary to pass on a part of the higher costs to customers while keeping the impact to a minimum.

2. Aurobindo Pharma Ltd

Aurobindo Pharma Ltd said its wholly owned subsidiary, CuraTeQ Biologics Pvt Ltd, has received regulatory approval from Brazil's National Health Surveillance Agency (ANVISA) for its biosimilars manufacturing facility in Hyderabad.

The approval follows a Good Manufacturing Practices (GMP) inspection conducted between May 11 and May 15, 2026. The inspection covered both biological active pharmaceutical ingredients (API) and sterile products. The regulatory clearance strengthens CuraTeQ's presence in international markets and could support the company's expansion in the global biosimilars business.

3. JSW Infrastructure Ltd

JSW Infrastructure Ltd reported a healthy financial performance for the quarter ended June 30, 2026, supported by higher cargo volumes and steady growth in revenue.

Cargo handled during the quarter rose 6 per cent year-on-year to 31 million tonnes. Revenue from operations increased 18 per cent year-on-year to Rs 1,445 crore, while operating EBITDA grew 16 per cent to Rs 674 crore. Profit before Tax stood at Rs 463 crore and profit after tax came in at Rs 358 crore during the quarter.

Disclaimer: The article is for informational purposes only and not investment advice.